Profil aset
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system. Its product candidates are targeted, receptor-specific therapeutics for the tre…
Terbaru dulu.
Palatin Memajukan Agonis PL2000 MC4R ke Fase 1 pada H1 2027
Obat dan kandidat lain dari perusahaan yang sama yang dipantau di sektor ini.